Felipe Meira De-Faria

Felipe Meira De-Faria

Auto-generated profile, based on publicly available information

Felipe Meira De-Faria

Centre for Social and Affective Neuroscience, Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
ARAriane Rozza
Ariane Rozza
FFFelipe Meira de Faria
Felipe Meira de Faria
ABAlba Regina Souza Brito
Alba Regina Souza Brito
CPClaudia H Pellizzon
Claudia H Pellizzon
The aim of this research was to investigate the anti-apoptotic, antioxidant and anti-inflammatory properties of menthol against ethanol-induced gastric ulcers in rats. Wistar rats were orally treated with vehicle, carbenoxolone (100 mg/kg) or menthol (50 mg/kg) and then treated with ethanol to induce gastric ulcers. After euthanasia, stomach samples were prepared for histological slides and biochemical analyses. Immunohistochemical analyses of the cytoprotective and anti-apoptotic heat-shock protein-70 (HSP-70) and the apoptotic Bax protein were performed. The neutrophils were manually counted. The activity of the myeloperoxidase (MPO) was measured. To determine the level of antioxidant functions, the levels of glutathione (GSH), glutathione peroxidase (GSH-Px), glutathione reductase (GR) and superoxide dismutase (SOD) were measured using ELISA. The levels of the pro-inflammatory cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and the anti-inflammatory cytokine interleukin-10 (IL-10) were assessed using ELISA kits. The menthol treated group presented 92% gastroprotection compared to the vehicle-treated group. An increased immunolabeled area was observed for HSP-70, and a decreased immunolabeled area was observed for the Bax protein in the menthol treated group. Menthol treatment induced a decrease in the activity of MPO and SOD, and the protein levels of GSH, GSH-Px and GR were increased. There was also a decrease in the levels of TNF-α and IL-6 and an increase in the level of IL-10. In conclusion, oral treatment with menthol displayed a gastroprotective activity through anti-apoptotic, antixidant and anti-inflammatory mechanisms.

1 April 2014 in Chemico-Biological Interactions
Verified
Journal Article
Closed access
FBFlavia Bonamin
Flavia Bonamin
TMThiago M. Moraes
Thiago M. Moraes
RSRaquel C. dos Santos
Raquel C. dos Santos
HKHélio Kushima
Hélio Kushima
FFFelipe M. Faria
Felipe M. Faria
CHClelia Hiruma-Lima
Clelia Hiruma-Lima

1 August 2016 in Nature Communications
Verified
Journal Article
Open access
PDF file
HEHelena Escuin-Ordinas
Helena Escuin-Ordinas
SLShuoran Li
Shuoran Li
MXMichael W. Xie
Michael W. Xie
LSLu Sun
Lu Sun
WHWilly Hugo
Willy Hugo
ARAntoni Ribas
Antoni Ribas
BRAF inhibitors are highly effective therapies for the treatment of BRAFV600-mutated melanoma, with the main toxicity being a variety of hyperproliferative skin conditions due to paradoxical activation of the mitogen-activated protein kinase (MAPK) pathway in BRAF wild-type cells. Most of these hyperproliferative skin changes improve when a MEK inhibitor is co-administered, as it blocks paradoxical MAPK activation. Here we show how the BRAF inhibitor vemurafenib accelerates skin wound healing by inducing the proliferation and migration of human keratinocytes through extracellular signal-regulated kinase (ERK) phosphorylation and cell cycle progression. Topical treatment with vemurafenib in two wound-healing mice models accelerates cutaneous wound healing through paradoxical MAPK activation; addition of a mitogen-activated protein kinase kinase (MEK) inhibitor reverses the benefit of vemurafenib-accelerated wound healing. The same dosing regimen of topical BRAF inhibitor does not increase the incidence of cutaneous squamous cell carcinomas in mice. Therefore, topical BRAF inhibitors may have clinical applications in accelerating the healing of skin wounds.

1 April 2011 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
CTChristiane Takayama
Christiane Takayama
FDFelipe Meira De-Faria
Felipe Meira De-Faria
AAAna Cristina Alves de Almeida
Ana Cristina Alves de Almeida
DVDeborah de Arantes e Oliveira Valim-Araújo
Deborah de Arantes e Oliveira Valim-Araújo
CRCamilla Souza Rehen
Camilla Souza Rehen
ASAlba Regina Monteiro Souza-Brito
Alba Regina Monteiro Souza-Brito

1 January 2012 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
FDFelipe Meira De-Faria
Felipe Meira De-Faria
AAAna Cristina Alves Almeida
Ana Cristina Alves Almeida
Anderson Luiz-FerreiraAnderson Luiz-Ferreira
Anderson Luiz-Ferreira
RDRicardo José Dunder
Ricardo José Dunder
CTChristiane Takayama
Christiane Takayama
ASAlba Regina Monteiro Souza-Brito
Alba Regina Monteiro Souza-Brito

9 January 2017 in Evidence-Based Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
AAAna Cristina Alves De Almeida
Ana Cristina Alves De Almeida
FDFelipe Meira De-Faria
Felipe Meira De-Faria
RDRicardo José Dunder
Ricardo José Dunder
LMLuis Paulo Manzo
Luis Paulo Manzo
ASAlba Regina Monteiro Souza-Brito
Alba Regina Monteiro Souza-Brito
Anderson Luiz-FerreiraAnderson Luiz-Ferreira
Anderson Luiz-Ferreira
Inflammatory bowel disease (IBD) is a chronic and disrupted inflammation of the gastrointestinal tract. IBD have two main conditions, Crohn’s disease and ulcerative colitis, and have been extensively investigated in recent years. Antibiotics derived from salicylates, steroids, immunosuppressors, and anti‐TNF therapy are part of the therapeutic arsenal for IBD. However, very often patients stop responding to treatments over the time. In this context, searching for alternative agents is crucial for IBD clinical management. Natural products derived from medicinal plants are an interesting therapeutic alternative, since several studies have proven effective treatments in animal models of intestinal inflammation. Several naturally occurring compounds are potent antioxidants, both as free radical scavengers and as modulators of antioxidant enzymes expression and activity. A number of natural compounds have also been proved to inhibit the release of proinflammatory cytokines, decreasing the activation of nuclear factorκB (NF‐κB), which is important to the inflammatory response in IBD. The alkaloids are substances of a very diverse class of plant secondary metabolites; an extensive list of biological activities has been attributed to alkaloids, such as being anticholinergic, antitumor, diuretic, antiviral, antihypertensive, antiulcer, analgesic, and anti‐inflammatory. In the present work, studies on the pharmacological activity of alkaloids in experimental models of IBD were reviewed.